C07D 209/38
In positions 2 and 3
Official title: in positions 2 and 3, e.g. isatin
C07D209/38 (In positions 2 and 3) appears on 178 US grants and 133 published applications in this corpus.
Search patents in C07D- Granted patents
- 178
- Published applications
- 133
- Assignees
- 125
- Inventors
- 437
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 8 | 0 |
| 1985 | 4 | 0 |
| 1986 | 8 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 5 |
| 2004 | 3 | 4 |
| 2005 | 2 | 2 |
| 2006 | 4 | 13 |
| 2007 | 4 | 6 |
| 2008 | 5 | 14 |
| 2009 | 3 | 5 |
| 2010 | 5 | 6 |
| 2011 | 7 | 9 |
| 2012 | 4 | 4 |
| 2013 | 4 | 5 |
| 2014 | 7 | 1 |
| 2015 | 6 | 8 |
| 2016 | 3 | 4 |
| 2017 | 11 | 7 |
| 2018 | 3 | 6 |
| 2019 | 5 | 4 |
| 2020 | 2 | 3 |
| 2021 | 5 | 1 |
| 2022 | 1 | 5 |
| 2023 | 2 | 9 |
| 2024 | 1 | 3 |
| 2025 | 4 | 3 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods to of aldehyde dehydrogenases for treatment of cancer5 May 2026US 12,616,678 B2The Penn State Research Foundation
- Nitrosation reagents and methods4 Nov 2025US 12,459,909 B2The Regents of the University of California
- 3-hydroxyoxindole derivatives as CRHR2 antagonist23 Sep 2025US 12,421,191 B2RaQualia Pharma Inc.
- Isatin derivative redoxamer for electrochemical device3 Jun 2025US 12,322,757 B2Uchicago Argonne, LLC
- Process for synthesis of 2-amino-5-chloro-N-,3-dimethylbenzamide20 May 2025US 12,304,893 B2FMC Corporation
- New process for the manufacture of mdm2-p53 antagonists23 Jul 2026US 2026/0209169 A1Boehringer Ingelheim International GmbH
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Allosteric modulation of muscarinic acetylcholine receptor efficacy23 Apr 2026US 2026/0109674 A1The Penn State Research Foundation
- Nitrosation Reagents and Methods9 Apr 2026US 2026/0098021 A1
- Indolinone compounds and uses thereof19 Mar 2026US 2026/0076941 A1Georgetown University
Most cited
By later US patents
- Inhibitors of factor Xa89US 6,534,535 B1Millennium Pharmaceuticals, Inc. · 2003
- 5-fluoroanthranilic fungicides76US 5,093,364 ASchering Agrochemicals Limited · 1992
- Diazepine derivatives67US 4,353,827 AHoffmann-La Roche Inc. · 1982
- Derivatization of non-natural amino acids and polypeptides61US 7,385,028 B2Ambrx, Inc. · 2008
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides60US 7,332,571 B2Ambrx, Inc. · 2008